Haleon to Invest ₹2,000 Crore in First India Manufacturing Facility at Pithampur

manufacturing-news
Image Courtesy: Haleon

Consumer health company Haleon has announced plans to establish its first manufacturing facility in India with an investment of approximately ₹2,000 crore. The new greenfield plant will be developed at Pithampur’s Smart Industrial Park in Madhya Pradesh and is expected to become a key manufacturing and export hub for the company in the region.

The announcement was made in the presence of Madhya Pradesh Chief Minister Dr Mohan Yadav, Haleon Chief Executive Officer Brian McNamara, Haleon India and India Subcontinent President Kedar Lele, and Chief Supply Chain Officer Namrata Patel. Spread across more than 40 acres, the facility represents one of the company’s largest investments in India and reinforces its long-term commitment to one of the world’s fastest-growing consumer health markets. The project is designed to strengthen local manufacturing capabilities, improve supply-chain resilience, and support exports to markets across Asia.

The manufacturing site is expected to create up to 500 direct employment opportunities while generating additional indirect jobs through local supplier networks and supporting industries. The company also plans to promote workforce diversity and aims to build a strong representation of women employees at the facility.

Chief Minister Dr Yadav said the investment highlights growing confidence among global corporations in Madhya Pradesh’s industrial ecosystem. He noted that the state’s infrastructure, skilled workforce, and investor-friendly policies continue to attract significant domestic and international investments.

Brian McNamara, Chief Executive Officer of Haleon, described India as a strategically important market for the company’s future growth. He stated that the investment would expand local manufacturing capabilities, strengthen market reach, and support the company’s ambition to make trusted health and wellness products accessible to millions of additional consumers.

Kedar Lele, CEO India and President, India Subcontinent, emphasized that the facility will help the company meet rising demand for consumer healthcare products while strengthening exports and supporting long-term growth. He also acknowledged the support provided by the Government of Madhya Pradesh and the Madhya Pradesh Industrial Development Corporation in facilitating the project. Built on Haleon’s latest global manufacturing blueprint, the facility will incorporate advanced automation and modern production technologies. Operations are expected to commence by 2029-30.

The investment further strengthens Haleon’s presence in India, where its portfolio includes well-known brands across oral health, digestive health, respiratory care, pain management, and nutritional supplements. The new facility is expected to play an important role in expanding access to healthcare products while contributing to economic development and industrial growth in the region.